Our research projects
Find out more about the research projects you're helping us to fund. Together we can beat blood cancer.
Understanding more about the alterations in our cells that can cause myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML)
Dr Quek is conducting research into the cellular process that causes AML and MDS to develop.
Understanding why some people with chronic lymphocytic leukaemia (CLL) get more infections
Dr Quek wants to better understand why many people with CLL have a high risk of developing infections following treatment by analysing blood and immune cells.
Understanding more the use of CT scans for children with blood cancer
Dr McNally’s research is exploring patterns in data to try to understand any potential risk of CT scans to help doctors to personalise treatment to each child based on their individual risk level.
Using NHS Data to Improve treatment for people with myeloma
Professor Cairns is researching a way to use existing NHS data to better understand how well treatments work in the long-term for people with myeloma.
Unlocking new hope: developing new, effective treatments for people with myeloma and AML
Read about how Dr Luciano Nicosia is investigating a new drug to see if it might be a new way to treat myeloma and AML.
Understanding the biology of aggressive DLBCL
Researchers are studying changes in the DNA of an aggressive type of DLBCL. This could lead to new treatments and a better chance of survival.
Developing new targeted treatments for B-cell lymphomas
Professor Pavel Tolar and his team are researching how receptors on the surface of B cells influence lymphoma growth.
Finding new ways to stop leukaemia and lymphoma growing
Dr Feldhahn and team want to create new ways to study 'enhancers' so they can understand which ones are helping blood cancers to grow.
Improving CART-cell therapy for people with T-cell acute lymphoblastic leukaemia (T-ALL)
Dr Maciocia is researching ways to help improve a new CART-cell therapy, making it more effective so people remain cancer free for longer.
Mapping gene changes in ALL
A change in the BCR‑ABL gene can trigger acute lymphoblastic leukaemia (ALL). Dr Niklas Feldahn's research is uncovering what drives this process.
Revolutionising stem cell transplants to treat acute myeloid leukaemia (AML)
Professor Wynn is developing and testing a new type of stem cell transplant which he hopes could be a better treatment option for people with acute myeloid leukaemia (AML)
Finding new ways to target blood cancer with less side effects
Dr Mihkel Örd is studying molecules that block a key protein used by blood cancers, with the aim of developing better treatments with fewer side effects.
Finding new drug treatments that help the body’s immune system to treat myeloma
Dr Dimeloe plans to test drugs used to treat other diseases to see if these can help the body’s immune cells to destroy cancerous myeloma cells.
Understanding the risk of covid for people with blood cancer
Professor Hippisley-Cox and her team at the University of Oxford are conducting research to understand more about new treatments for people who are at a higher risk of getting ill from covid to see how effective they are.
Understanding the role of genes in how ALL develops in children
Dr Wright and team want to understand more about graft verses leukaemic (GVL) effect and graft-versus-host disease (GVHD) after a bone marrow transplant.
Using immune cells to create a new CAR-T therapy for multiple myeloma
Read more about how Professor Karadimitris and his team are researching a new treatment for myeloma that uses special immune cells.
Understanding why CAR-T cell therapy works for some people but doesn't work for others
Dr Claire Roddie is researching to understand why CAR-T cell therapy is an effective treatment for some people with blood cancer but doesn't work well for everyone.
Understanding the best way to treat follicular lymphoma
Dr Linton is researching how the order in which treatments are given can affect outcomes for people with follicular lymphoma to find the best way to treat the disease.
Discovering a less harmful way to treat blood cancers caused by the Epstein-Barr virus (EBV)
Professor West is working to create a targeted treatment for EBV‑positive cancers that leaves healthy cells unharmed.
Trialling a personalised treatment approach for myeloma – The iFIT trial
We’re funding the iFIT trial in partnership with Cancer Research UK at the University of Leeds Institute of Clinical Trials Research.
Understanding how a virus can cause lymphoma
Dr Radzisheuskaya is seeking to understand the roles of specific proteins so she can develop more effective treatments for people with AML.
Keep in touch with us
Get the latest news from Blood Cancer UK directly to your inbox
We will keep you updated about our work and the ways you can help, including campaigns and events. We promise to respect your privacy and we will never sell or swap your details.